Skip to main content
SpringerLink
Log in
Book cover

Cell Therapy pp 281–295Cite as

Cell Therapy: Approaching a Partnership with Pharma

  • Chapter
  • First Online:

  • 1286 Accesses

Part of the book series: Molecular and Translational Medicine ((MOLEMED))

Abstract

The translation of cell biology science to an applied medical therapy holds great allure for forward-thinkers in the medical industry. As with any other futuristic technologies, exotic therapies need to be more medically effective than current treatments, sufficiently robust to be scaled reproducibly, and economically viable as a commercial product. This chapter is a primer on what an academic cell biologist/inventor may expect when seeking funding from a typical pharmaceutical company to develop a cell therapy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Haucap J, Stiebale J. Research: innovation suffers when drug companies merge. Harv Bus Rev (online). 2016. Accessed 19 Oct 2016.

  2. Cyran R. Change is in the air for pharmaceutical mergers. New York Times (online). 2016. Accessed 19 Oct 2016.

  3. Smith AG. Price gouging and the dangerous new breed of pharma company. Harv Bus Rev (online). 2016. Accessed 19 Oct 2016.

  4. Thomas H. GSK’s sturdy strategy leaves investors waiting. Wall Street J (online). 2015. Accessed 19 Oct 2016.

  5. DiMasi J, Grabnowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20–33. doi:10.1016/j.jhealeco.2016.01.012.

    Article  PubMed  Google Scholar 

  6. Bajak A. Will embryonic stem cells cure anything? MIT Technol Rev (online). 2016. Accessed 19 Oct 2016.

  7. Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25(5):829–48. doi:10.3727/096368915X689622.

    Article  PubMed  Google Scholar 

  8. Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Leselbaum A, Danese S, ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016;388(10051):1281–90. doi:10.1016/S0140-6736(16)31203-X.

    Article  PubMed  Google Scholar 

  9. Jackson HJ, Rafiq S, Brentjens RJ. Driving CAR T-cells forward. Nat Rev Clin Oncol. 2016;13(6):370–83. doi:10.1038/nrclinonc.2016.36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bonifant CL, Jackson HJ, Brentjens RJ, Curran KJ. Toxicity and management in CAR T-cell therapy. Mol Ther Oncolytics. 2016;3:16011. doi:10.1038/mto.2016.11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Wang X, Rivière I. Clinical manufacturing of CAR T cells: foundation of a promising therapy. Mol Ther Oncolytics. 2016;3:16015. doi:10.1038/mto.2016.15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lathuilière A, Mach N, Schneider BL. Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system. Int J Mol Sci. 2015;16(5):10578–600. doi:10.3390/ijms160510578.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kauper K, McGovern C, Sherman S, Heatherton P, Rapoza R, Stabila P, Dean B, Lee A, Borges S, Bouchard B, Tao W. Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases. Invest Ophthalmol Vis Sci. 2012;53(12):7484–91. doi:10.1167/iovs.12-9970.

    Article  CAS  PubMed  Google Scholar 

  14. Ling V, Nystuen A, Elliott S, Orecchio L, Dean B, Kauper K, Tao W. Generation of Combination PDGF/VEGF-antagonist ECT devices. Invest Ophthalmol Vis Sci. 2013;54:3290.

    Google Scholar 

  15. Wahlberg LU, Lind G, Almqvist PM, Kusk P, Tornøe J, Juliusson B, Söderman M, Selldén E, Seiger Å, Eriksdotter-Jönhagen M, Linderoth B. Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer’s disease: a technology platform for restorative neurosurgery. J Neurosurg. 2012;117(2):340–7. doi:10.3171/2012.2.JNS11714.

    Article  PubMed  Google Scholar 

  16. Lathuilière A, Mach N, Schneider BL. Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system. Int J Mol Sci. 2015;16(5):10578–600. doi:10.3390/ijms160510578.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. BioEntrepreneur, 1600 Providence Hwy #247, Walpole, MA, 02081, USA

    Vincent Ling Ph.D.

Authors
  1. Vincent Ling Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vincent Ling Ph.D. .

Editor information

Editors and Affiliations

  1. NsGene, Inc., Providence, Rhode Island, USA

    Dwaine F. Emerich

  2. Paseo de la Universidad 7, Vitoria-Gasteiz, Spain

    Gorka Orive

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Ling, V. (2017). Cell Therapy: Approaching a Partnership with Pharma. In: Emerich, D., Orive, G. (eds) Cell Therapy. Molecular and Translational Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-57153-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-57153-9_13

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-57152-2

  • Online ISBN: 978-3-319-57153-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation